Dechra is a company with a track record of growth. Our pharmaceutical sales revenue topped £189 m in 2013, with 89% of this coming from Europe. We continue to invest in new products with 8 novel products and 3 differentiated generics in our product pipeline.
Despite the fact that we have grown rapidly, we have stayed true to who we are. We have not forgotten our roots and we remain a small and responsive company at heart.
Our key areas of expertise span endocrinology, dermatology, cardiology, water soluble powder products and injectable antibiotics, anaesthetics and analgesics, equine medicine and diet and nutrition. Our major products include:
Sign up today. It is free and only takes a few minutes.
If this is your first visit to the upgraded sites you need to re-set your password